Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

Share Price is delayed by 15 minutes
Get Live Data
106.00    -1.00 (-0.93%)
Bid:
106.00
Ask:
110.50
Spread: 4.50 (4.245%)
Market Cap: £104.46m
ECEL Live PriceLast checked at - London Stock Exchange

Intraday Eurocell Share Chart

Awards to Directors and PDMRs

30 Jun 2016 07:00

RNS Number : 7227C
Eurocell plc
29 June 2016
 

Eurocell plc

 

29 June 2016

 

 

 

 

Notification made in accordance with Rule 3.1.4(1)(a) of the Disclosure and Transparency Rules.

 

Eurocell plc, (LSE: ECEL) a market leading, vertically integrated UK manufacturer and distributor of innovative window, door and roofline PVC products, announces that awards have been granted to Mark Kelly, Chief Executive, and certain other persons discharging managerial responsibilities ("PDMRs") under the terms of the Eurocell plc Performance Share Plan 2015 ("PSP") and the Eurocell plc Deferred Share Plan 2015 ("DSP").

 

Award granted under the PSP

 

A nil-cost option over 273,417 ordinary shares of £0.001 each ("Ordinary Shares") was granted to Mark Kelly, Chief Executive of the Company, under the PSP on 28 June 2016.

 

The vesting of the PSP award is subject to certain conditions including continued employment with the Group and the achievement of performance targets related to earnings per share growth and group cash flow over a three year performance period.

 

This award represents a formalisation of the share options announced on 7 April 2016 and is not in addition to those share options.

 

Awards granted under the DSP

 

Nil-cost options were granted under the DSP on 28 June 2016 to Mark Kelly and to certain PDMRs over Ordinary Shares as follows:

 

 

Name

 

Director/PDMR

 

Number of Ordinary Shares subject to award

 

Mark Kelly

 

Director

119,424

Ian Kemp

 

PDMR

7,378

Anthony Smith

 

PDMR

 

8,077

Glenn Parkinson

 

PDMR

 

8,200

 

 

The award granted to Mark Kelly vests on 28 June 2017 subject to continued employment with the Group and relates to his recruitment bonus, as previously disclosed in the Directors' Remuneration Report contained in the Company's 2015 Annual Report. Each of the other DSP awards described above vests on 28 June 2019 subject to continued employment with the Group.

 

Robert Lawson, Chairman of Eurocell, commented:

 

"The grant of these options will enable key members of our team to benefit from the strong future growth that we believe Eurocell can achieve and ensures that their interests are in line with our shareholders. The awards are in line with the remuneration policy set out at our IPO in 2015."

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUKARRNWANUUR
Date   Source Headline
18th May 20264:00 pmRNSDirector/PDMR Shareholding
14th May 20261:49 pmRNSResult of AGM
14th May 20267:00 amRNSTrading Update
1st May 20267:00 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSLeadership Update - CFO Appointment
15th Apr 20267:00 amRNSPublication of 2025 Annual Report & Notice of AGM
23rd Mar 202610:15 amRNSDirector/PDMR Shareholding
19th Mar 202610:30 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSPRELIMINARY RESULTS FOR THE YEAR ENDED 31 DEC 2025
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
16th Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSTransaction in Own Shares - Buyback Complete
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20261:00 pmRNSDirectorate changes
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSDirector/PDMR Shareholding
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSYear End Trading Update
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:00 pmRNSPurchase of Shares via Employee Benefit Trust
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.